Avalglucosidase Alfa

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Glycogen Storage Disease Type II Pompe Disease

Drug Information

Target Indication

Glycogen Storage Disease Type II Pompe Disease

Clinical Trial

Last updated: 2/25/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

SNYNF

Sanofi

Related Pipeline

Atrial Fibrillation

Glycogen Storage Disease Type II

Inappropriate ADH Syndrome

Sphingomyelin Lipidosis

Chronic Obstructive Pulmonary Disease